Last updated: 07/17/2024 15:44:10

SAS115359: A 6-month study to assess the safety and benefit of inhaled fluticasone propionate/salmeterol combination compared with inhaled fluticasone propionate in the treatment of adolescents and adults (12 years of age and older) with asthma.AUSTRI

GSK study ID
115359
Clinicaltrials.gov ID
EudraCT ID
EU CT Number
Not applicable
Trial status
Completed
Completed
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: SAS115359, a Safety and Efficacy Study of Inhaled Fluticasone Propionate/Salmeterol Combination versus Inhaled Fluticasone Propionate in the Treatment of Adolescent and Adult Subjects with Asthma
Trial description: The purpose of this study is to assess whether the risk of serious asthma-related events (asthma-related hospitalizations, endotracheal intubations, and deaths) in adolescents and adults (12 years of age and older) taking inhaled fluticasone propionate/salmeterol combination is the same as those taking inhaled fluticasone propionate alone.
ADVAIR™ and FLOVENT™ are trademarks of the GlaxoSmithKline Group of Companies.
Primary purpose:
Treatment
Trial design:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Investigator)
Allocation:
Randomized
Primary outcomes:

Number of participants experiencing an event in the composite safety endpoint of serious asthma outcomes ( asthma-related hospitalization, asthma-related endotracheal intubation, or asthma-related death)

Timeframe: From Day 1 up to 26 weeks

Number of participants experiencing at least one asthma exacerbation

Timeframe: From Day 1 up to 26 weeks

Secondary outcomes:

Number of participants experiencing at least one asthma related hospitalization , endotracheal intubation and death

Timeframe: From Day 1 up to 26 weeks

Number of participant withdrawals from study treatment due to asthma exacerbation

Timeframe: From Day 1 up to 26 weeks

Mean rescue medication (albuterol/salbutamol) use as puffs per 24 hours

Timeframe: From Day 1 up to 26 weeks

Interventions:
Drug: ADVAIR 100/50mcg
Drug: ADVAIR 250/50mcg
Drug: ADVAIR 500/50mcg
Drug: FLOVENT 100mcg
Drug: FLOVENT 250mcg
Drug: FLOVENT 500mcg
Enrollment:
11751
Observational study model:
Not applicable
Primary completion date:
2015-23-06
Time perspective:
Not applicable
Clinical publications:
Stempel D, Raphiou I, Kral, K, Yeakey A, Emmett A, Prazma C, Buaron K, Pascoe S.Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone.N Engl J Med.2016;374:1822-1830.
Stanley Szefler, Ibrahim Raphiou, Robert S. Zeiger, David Stempel, Kenneth Kral, Steven Pascoe.Seasonal variation in asthma exacerbations in the AUSTRI and VESTRI studies .ERJ Open Res.2019;5:1-4 DOI: 10.1183/23120541.00153-2018
Medical condition
Asthma
Product
fluticasone propionate, fluticasone propionate/salmeterol, salmeterol
Collaborators
Parexel
Study date(s)
November 2011 to June 2015
Type
Interventional
Phase
4

Participation criteria

Sex
Female & Male
Age
12+ years
Accepts healthy volunteers
No
  • Provided consent to participate in the study
  • Male or female, 12 years of age and older
  • History of life threatening asthma defined for this protocol as asthma episode that required intubation and/or was associated with hypercapnea requiring non-invasive ventilatory support
  • Concurrent respiratory disease other than asthma

Trial location(s)

Location
Status
Contact us
Contact us
Location
GSK Investigational Site
ALOR SETAR, Malaysia, 05460
Status
Study Complete
Location
GSK Investigational Site
Aguascalientes, Ags, Aguascalientes, Mexico, 20127
Status
Study Complete
Location
GSK Investigational Site
Albuquerque, New Mexico, United States, 87131
Status
Study Complete
Location
GSK Investigational Site
Anaheim, California, United States, 92801
Status
Study Complete
Location
GSK Investigational Site
Anaheim, California, United States, 92804
Status
Study Complete
Location
GSK Investigational Site
Ann Arbor, Michigan, United States, 48106
Status
Study Complete
Location
GSK Investigational Site
Annapolis, Maryland, United States, 21401
Status
Study Complete
Location
GSK Investigational Site
Arenzano, Liguria, Italy, 16011
Status
Study Complete
Location
GSK Investigational Site
Arlington, Texas, United States, 76018
Status
Study Complete
Location
GSK Investigational Site
Asheboro, North Carolina, United States, 27203
Status
Study Complete
Location
GSK Investigational Site
Asheville, North Carolina, United States, 28803
Status
Study Complete
Location
GSK Investigational Site
Atco, New Jersey, United States, 08004
Status
Study Complete
Location
GSK Investigational Site
Athens, Alabama, United States, 35611
Status
Study Complete
Location
GSK Investigational Site
Auerbach, Sachsen, Germany, 08209
Status
Study Complete
Location
GSK Investigational Site
Augsburg, Bayern, Germany, 86150
Status
Study Complete
Location
GSK Investigational Site
Austell, Georgia, United States, 30106
Status
Study Complete
Location
GSK Investigational Site
Austin, Texas, United States, 78731
Status
Study Complete
Location
GSK Investigational Site
Austin, Texas, United States, 78758
Status
Study Complete
Location
GSK Investigational Site
Austin, Texas, United States, 78759-8950
Status
Study Complete
Location
GSK Investigational Site
Avon, Indiana, United States, 46123
Status
Study Complete
Location
GSK Investigational Site
Bad Pyrmont, Niedersachsen, Germany, 31812
Status
Study Complete
Location
GSK Investigational Site
Bad Woerrishofen, Bayern, Germany, 86825
Status
Study Complete
Location
GSK Investigational Site
Baja, Hungary, 6500
Status
Study Complete
Location
GSK Investigational Site
Bakerfield, California, United States, 93301
Status
Study Complete
Location
GSK Investigational Site
Balassagyarmat, Hungary, 2660
Status
Study Complete
Location
GSK Investigational Site
Baltimore, Maryland, United States, 21224
Status
Study Complete
Location
GSK Investigational Site
Bangor, Maine, United States, 04401
Status
Study Complete
Location
GSK Investigational Site
Barcelona, Spain, 08022
Status
Study Complete
Location
GSK Investigational Site
Barcelona, Spain, 08036
Status
Study Complete
Location
GSK Investigational Site
Barcelona, Spain, 8036
Status
Study Complete
Location
GSK Investigational Site
Barry, United Kingdom, CF63 4AR
Status
Study Complete
Location
GSK Investigational Site
Basurto/Bilbao, Spain, 48013
Status
Study Complete
Location
GSK Investigational Site
Bedford Park, South Australia, Australia, 5042
Status
Study Complete
Location
GSK Investigational Site
Belgrade, Serbia, 11000
Status
Study Complete
Location
GSK Investigational Site
Bell Vernon, Pennsylvania, United States, 15012
Status
Study Complete
Location
GSK Investigational Site
Belle Vernon, Pennsylvania, United States, 15012
Status
Study Complete
Location
GSK Investigational Site
Bellevue, Nebraska, United States, 68005
Status
Study Complete
Location
GSK Investigational Site
Bellingham, Washington, United States, 98225
Status
Study Complete
Location
GSK Investigational Site
Bellville, South Africa, 7531
Status
Study Complete
Location
GSK Investigational Site
Benoni, South Africa, 1501
Status
Study Complete
Location
GSK Investigational Site
Bensalem, Pennsylvania, United States, 19020
Status
Study Complete
Location
GSK Investigational Site
Bensheim, Hessen, Germany, 64625
Status
Study Complete
Location
GSK Investigational Site
Bergisch Gladbach, Nordrhein-Westfalen, Germany, 51429
Status
Study Complete
Location
GSK Investigational Site
Berlin, Berlin, Germany, 10629
Status
Study Complete
Location
GSK Investigational Site
Berlin, Berlin, Germany, 10787
Status
Study Complete
Location
GSK Investigational Site
Berlin, Berlin, Germany, 12099
Status
Study Complete
Location
GSK Investigational Site
Berlin, Berlin, Germany, 12157
Status
Study Complete
Location
GSK Investigational Site
Berlin, Berlin, Germany, 13086
Status
Study Complete
Location
GSK Investigational Site
Berlin, Berlin, Germany, 13156
Status
Study Complete
Location
GSK Investigational Site
Berlin, Berlin, Germany, 13187
Status
Study Complete
Location
GSK Investigational Site
Berlin, Berlin, Germany, 14050
Status
Study Complete
Location
GSK Investigational Site
Bexhill-on-Sea, United Kingdom, TN40 1JJ
Status
Study Complete
Location
GSK Investigational Site
Bielsko-Biala, Poland, 43-300
Status
Study Complete
Location
GSK Investigational Site
Billings, Montana, United States, 59101
Status
Study Complete
Location
GSK Investigational Site
Birmingham, Alabama, United States, 35209
Status
Study Complete
Location
GSK Investigational Site
Birmingham, Alabama, United States, 35216
Status
Study Complete
Location
GSK Investigational Site
Birmingham, Alabama, United States, 35233
Status
Study Complete
Location
GSK Investigational Site
Blagoevgrad, Bulgaria, 2700
Status
Study Complete
Location
GSK Investigational Site
Bochum, Nordrhein-Westfalen, Germany, 44791
Status
Study Complete
Location
GSK Investigational Site
Boehlen, Sachsen, Germany, 04564
Status
Study Complete
Location
GSK Investigational Site
Bogota, Colombia, N/A
Status
Study Complete
Location
GSK Investigational Site
Bonn, Nordrhein-Westfalen, Germany, 53119
Status
Study Complete
Location
GSK Investigational Site
Bonn, Nordrhein-Westfalen, Germany, 53123
Status
Study Complete
Location
GSK Investigational Site
Boynton Beach, Florida, United States, 33437
Status
Study Complete
Location
GSK Investigational Site
Brampton, Ontario, Canada, L6T3J1
Status
Study Complete
Location
GSK Investigational Site
Brandon, Florida, United States, 33511
Status
Study Complete
Location
GSK Investigational Site
Brasov, Romania, 500074
Status
Study Complete
Location
GSK Investigational Site
Brescia, Italy, 25123
Status
Study Complete
Location
GSK Investigational Site
Brick, New Jersey, United States, 08724
Status
Study Complete
Location
GSK Investigational Site
Brighton, Sussex East, United Kingdom, BN2 5BE
Status
Study Complete
Location
GSK Investigational Site
Bronx,, New York, United States, 10457
Status
Study Complete
Location
GSK Investigational Site
Brooklyn, New York, United States, 11215
Status
Study Complete
Location
GSK Investigational Site
Brownsburg, Indiana, United States, 46112
Status
Study Complete
Location
GSK Investigational Site
Brussels, Belgium, 1000
Status
Study Complete
Location
GSK Investigational Site
Brzesko, Poland, 32-800
Status
Study Complete
Location
GSK Investigational Site
Bucheon, South Korea, 420-717
Status
Study Complete
Location
GSK Investigational Site
Bucheon-si,, South Korea, 420-767
Status
Study Complete
Location
GSK Investigational Site
Buckley, Michigan, United States, 49620
Status
Study Complete
Location
GSK Investigational Site
Budapest, Hungary, 1089
Status
Study Complete
Location
GSK Investigational Site
Budapest, Hungary, 1117
Status
Study Complete
Location
GSK Investigational Site
Buenos Aires, Argentina, 1406
Status
Study Complete
Location
GSK Investigational Site
Buenos Aires, Argentina, 1602
Status
Study Complete
Location
GSK Investigational Site
Buenos Aires, Buenos Aires, Argentina, 1425
Status
Study Complete
Location
GSK Investigational Site
Burgos, Spain, 09005
Status
Study Complete
Location
GSK Investigational Site
Busan, South Korea, 602-715
Status
Study Complete
Location
GSK Investigational Site
Bystra, Poland, 43-360
Status
Study Complete
Location
GSK Investigational Site
CROWN POINT, Indiana, United States, 46307
Status
Study Complete
Location
GSK Investigational Site
Cakovec, Croatia, 40000
Status
Study Complete
Location
GSK Investigational Site
Calabash, North Carolina, United States, 28467
Status
Study Complete
Location
GSK Investigational Site
Canet de Mar - Barcelona, Spain, 08360
Status
Study Complete
Location
GSK Investigational Site
Cape Town, South Africa, 7500
Status
Study Complete
Location
GSK Investigational Site
Cape Town, South Africa, 7570
Status
Study Complete
Location
GSK Investigational Site
Cape Town, South Africa, 7700
Status
Study Complete
Location
GSK Investigational Site
Cape Town, Gauteng, South Africa, 7505
Status
Study Complete
Location
GSK Investigational Site
Cardiff, Glamorgan, United Kingdom, CF5 4AE
Status
Study Complete
Location
GSK Investigational Site
Carnegie, Pennsylvania, United States, 15106
Status
Study Complete
Location
GSK Investigational Site
Cary, North Carolina, United States, 27518
Status
Study Complete
Location
GSK Investigational Site
Catania, Sicilia, Italy, 95125
Status
Study Complete
Location
GSK Investigational Site
Centerville, Ohio, United States, 45459
Status
Study Complete
Location
GSK Investigational Site
Champaign, Illinois, United States, 61820
Status
Study Complete
Location
GSK Investigational Site
Chandler, Arizona, United States, 85224
Status
Study Complete
Location
GSK Investigational Site
Charlotte, North Carolina, United States, 28207
Status
Study Complete
Location
GSK Investigational Site
Chaska, Minnesota, United States, 55318
Status
Study Complete
Location
GSK Investigational Site
Chattanooga, Tennessee, United States, 37404
Status
Study Complete
Location
GSK Investigational Site
Chattanooga, Tennessee, United States, 37421
Status
Study Complete
Location
GSK Investigational Site
Chelsea, Michigan, United States, 48118
Status
Study Complete
Location
GSK Investigational Site
Chelyabinsk, Russia, 454021
Status
Study Complete
Location
GSK Investigational Site
Cherkassy, Ukraine, 18009
Status
Study Complete
Location
GSK Investigational Site
Chertsey, Surrey, United Kingdom, KT16 0PZ
Status
Study Complete
Location
GSK Investigational Site
Cincinnati, Ohio, United States, 45231
Status
Study Complete
Location
GSK Investigational Site
Cincinnati, Ohio, United States, 45236
Status
Study Complete
Location
GSK Investigational Site
Ciudad Autónoma de Buenos Aires, Argentina, C1121ABE
Status
Study Complete
Location
GSK Investigational Site
Claremont, South Africa, 7708
Status
Study Complete
Location
GSK Investigational Site
Clayton, Victoria, Australia, 3168
Status
Study Complete
Location
GSK Investigational Site
Clearwater, Florida, United States, 33756
Status
Study Complete
Location
GSK Investigational Site
Clearwater, Florida, United States, 33759
Status
Study Complete
Location
GSK Investigational Site
Cleveland, Ohio, United States, 44130
Status
Study Complete
Location
GSK Investigational Site
Clinton, Utah, United States, 84015
Status
Study Complete
Location
GSK Investigational Site
Cluj-Napoca, Romania, 400371
Status
Study Complete
Location
GSK Investigational Site
Cocoa, Florida, United States, 32927
Status
Study Complete
Location
GSK Investigational Site
Colorado Springs, Colorado, United States, 80906
Status
Study Complete
Location
GSK Investigational Site
Colorado Springs, Colorado, United States, 80907
Status
Study Complete
Location
GSK Investigational Site
Colorado Springs, Colorado, United States, 80909
Status
Study Complete
Location
GSK Investigational Site
Colorado Springs, Colorado, United States, 80922
Status
Study Complete
Location
GSK Investigational Site
Columbia, Maryland, United States, 21045
Status
Study Complete
Location
GSK Investigational Site
Columbia, South Carolina, United States, 29201
Status
Study Complete
Location
GSK Investigational Site
Columbus, Georgia, United States, 31904
Status
Study Complete
Location
GSK Investigational Site
Columbus, Ohio, United States, 43215
Status
Study Complete
Location
GSK Investigational Site
Concepcion del Uruguay, Entre Ríos, Argentina, 3260
Status
Study Complete
Location
GSK Investigational Site
Copenhagen, Denmark, 2400
Status
Study Complete
Location
GSK Investigational Site
Coral Gables, Florida, United States, 33134
Status
Study Complete
Location
GSK Investigational Site
Corning, New York, United States, 14830
Status
Study Complete
Location
GSK Investigational Site
Corsicana, Texas, United States, 75110
Status
Study Complete
Location
GSK Investigational Site
Council Bluffs, Iowa, United States, 51503
Status
Study Complete
Location
GSK Investigational Site
Covington, Louisiana, United States, 70433
Status
Study Complete
Location
GSK Investigational Site
Cádiz, Spain, 10009
Status
Study Complete
Location
GSK Investigational Site
Dakota Dunes, South Dakota, United States, 57049
Status
Study Complete
Location
GSK Investigational Site
Dallas, Texas, United States, 75225
Status
Study Complete
Location
GSK Investigational Site
Dallas, Texas, United States, 75230
Status
Study Complete
Location
GSK Investigational Site
Dallas, Texas, United States, 75246
Status
Study Complete
Location
GSK Investigational Site
Dallas, Texas, United States, 75254
Status
Study Complete
Location
GSK Investigational Site
Danbury, Connecticut, United States, 06810
Status
Study Complete
Location
GSK Investigational Site
Dasmariñas, Cavite, Philippines, 4114
Status
Study Complete
Location
GSK Investigational Site
Davao, Philippines, 8000
Status
Study Complete
Location
GSK Investigational Site
Dayton, Ohio, United States, 45406
Status
Study Complete
Location
GSK Investigational Site
Dayton, Ohio, United States, 45459
Status
Study Complete
Location
GSK Investigational Site
Debrecen, Hungary, 4026
Status
Study Complete
Location
GSK Investigational Site
Decatur, Georgia, United States, 30033
Status
Study Complete
Location
GSK Investigational Site
Deggingen, Baden-Wuerttemberg, Germany, 73326
Status
Study Complete
Location
GSK Investigational Site
Delitzsch, Sachsen, Germany, 04509
Status
Study Complete
Location
GSK Investigational Site
Denpasar, Indonesia, 80114
Status
Study Complete
Location
GSK Investigational Site
Denver, Colorado, United States, 80206
Status
Study Complete
Location
GSK Investigational Site
Depok Timur, Indonesia, 16411
Status
Study Complete
Location
GSK Investigational Site
Derqui, Pilar, Buenos Aires, Argentina, B1629AHJ
Status
Study Complete
Location
GSK Investigational Site
Destin, Florida, United States, 32541
Status
Study Complete
Location
GSK Investigational Site
Detroit, Michigan, United States, 48221
Status
Study Complete
Location
GSK Investigational Site
Detroit, Michigan, United States, 48235
Status
Study Complete
Location
GSK Investigational Site
Die Wilgers, South Africa, 0184
Status
Study Complete
Location
GSK Investigational Site
Dillingen, Saarland, Germany, 66763
Status
Study Complete
Location
GSK Investigational Site
Dinuba, California, United States, 93618
Status
Study Complete
Location
GSK Investigational Site
Dnipropetrovsk, Ukraine, 49027
Status
Study Complete
Location
GSK Investigational Site
Donetsk, Ukraine, 83059
Status
Study Complete
Location
GSK Investigational Site
Doral, Florida, United States, 33166
Status
Study Complete
Location
GSK Investigational Site
Doral, Florida, United States, 33172
Status
Study Complete
Location
GSK Investigational Site
Downington, Pennsylvania, United States, 19335
Status
Study Complete
Location
GSK Investigational Site
Duncanville, Texas, United States, 75116
Status
Study Complete
Location
GSK Investigational Site
Durban, South Africa, 4001
Status
Study Complete
Location
GSK Investigational Site
Durban, South Africa, 4071
Status
Study Complete
Location
GSK Investigational Site
Dębica, Poland, 39 – 200
Status
Study Complete
Location
GSK Investigational Site
East Greenwich, Rhode Island, United States, 02818
Status
Study Complete
Location
GSK Investigational Site
Edison, New Jersey, United States, 08817
Status
Study Complete
Location
GSK Investigational Site
Edison, New Jersey, United States, 08820
Status
Study Complete
Location
GSK Investigational Site
Edmonton, Alberta, Canada, T5A 4L8
Status
Study Complete
Location
GSK Investigational Site
Elblag, Poland, 82-300
Status
Study Complete
Location
GSK Investigational Site
Elche, Spain, 12203
Status
Study Complete
Location
GSK Investigational Site
Elizabeth, New Jersey, United States, 07201
Status
Study Complete
Location
GSK Investigational Site
Elizabeth, New Jersey, United States, 07202
Status
Study Complete
Location
GSK Investigational Site
Eloffsdal, Gauteng, South Africa, 0084
Status
Study Complete
Location
GSK Investigational Site
Engelskirchen, Nordrhein-Westfalen, Germany, 51766
Status
Study Complete
Location
GSK Investigational Site
Erie, Pennsylvania, United States, 16508
Status
Study Complete
Location
GSK Investigational Site
Essen, Nordrhein-Westfalen, Germany, 45136
Status
Study Complete
Location
GSK Investigational Site
Essen, Nordrhein-Westfalen, Germany, 45359
Status
Study Complete
Location
GSK Investigational Site
Eugene, Oregon, United States, 97401
Status
Study Complete
Location
GSK Investigational Site
Evergreen Park, Illinois, United States, 60805
Status
Study Complete
Location
GSK Investigational Site
Fall River, Massachusetts, United States, 02720
Status
Study Complete
Location
GSK Investigational Site
Falls Church, Vermont, United States, 22044
Status
Study Complete
Location
GSK Investigational Site
Fargo, North Dakota, United States, 58103
Status
Study Complete
Location
GSK Investigational Site
Fargo, North Dakota, United States, 58104
Status
Study Complete
Location
GSK Investigational Site
Feldkirch, Austria, 6800
Status
Study Complete
Location
GSK Investigational Site
Fenton, Michigan, United States, 48430
Status
Study Complete
Location
GSK Investigational Site
Firenze, Toscana, Italy, 50134
Status
Study Complete
Location
GSK Investigational Site
Flagstaff, Arizona, United States, 86001
Status
Study Complete
Location
GSK Investigational Site
Fort Collins, Colorado, United States, 80538
Status
Study Complete
Location
GSK Investigational Site
Fort Erie, Ontario, Canada, L2A 1X3
Status
Study Complete
Location
GSK Investigational Site
Fort Lauderdale, Florida, United States, 33316
Status
Study Complete
Location
GSK Investigational Site
Frankenberg, Hessen, Germany, 35066
Status
Study Complete
Location
GSK Investigational Site
Franklin, Indiana, United States, 46131
Status
Study Complete
Location
GSK Investigational Site
Fresno, California, United States, 93720
Status
Study Complete
Location
GSK Investigational Site
Gainesville, Georgia, United States, 30501
Status
Study Complete
Location
GSK Investigational Site
Gars am Inn, Bayern, Germany, 83536
Status
Study Complete
Location
GSK Investigational Site
Gatesville, South Africa, 7764
Status
Study Complete
Location
GSK Investigational Site
Gdansk, Poland, 84-462
Status
Study Complete
Location
GSK Investigational Site
Gdanska, Poland, 80-433
Status
Study Complete
Location
GSK Investigational Site
Georgensgmuend, Bayern, Germany, 91166
Status
Study Complete
Location
GSK Investigational Site
Glasgow, United Kingdom, G12 0YN
Status
Study Complete
Location
GSK Investigational Site
Glenview, Illinois, United States, 60025
Status
Study Complete
Location
GSK Investigational Site
Glucholazy, Poland, 41-340
Status
Study Complete
Location
GSK Investigational Site
Golden, Colorado, United States, 80401
Status
Study Complete
Location
GSK Investigational Site
Goodyear, Arizona, United States, 85395
Status
Study Complete
Location
GSK Investigational Site
Granada Hills, California, United States, 91344
Status
Study Complete
Location
GSK Investigational Site
Great Falls, Montana, United States, 59405
Status
Study Complete
Location
GSK Investigational Site
Green Valley, Arizona, United States, 85614
Status
Study Complete
Location
GSK Investigational Site
Greenville, South Carolina, United States, 29615
Status
Study Complete
Location
GSK Investigational Site
Greenwood, South Carolina, United States, 29646
Status
Study Complete
Location
GSK Investigational Site
Greer, South Carolina, United States, 29651
Status
Study Complete
Location
GSK Investigational Site
Groveport, Ohio, United States, 43125
Status
Study Complete
Location
GSK Investigational Site
Gun Barrel City, Texas, United States, 75156
Status
Study Complete
Location
GSK Investigational Site
Gwangju, South Korea, 501-757
Status
Study Complete
Location
GSK Investigational Site
Hagen, Nordrhein-Westfalen, Germany, 58089
Status
Study Complete
Location
GSK Investigational Site
Hamburg, Hamburg, Germany, 20354
Status
Study Complete
Location
GSK Investigational Site
Hamburg, Hamburg, Germany, 22335
Status
Study Complete
Location
GSK Investigational Site
Hamburg, Hamburg, Germany, 22767
Status
Study Complete
Location
GSK Investigational Site
Hampton, Virginia, United States, 23666
Status
Study Complete
Location
GSK Investigational Site
Harbor City, California, United States, 90710
Status
Study Complete
Location
GSK Investigational Site
Havlickuv brod, Czech Republic, 580 01
Status
Study Complete
Location
GSK Investigational Site
Hazard, Kentucky, United States, 41701
Status
Study Complete
Location
GSK Investigational Site
Henderson, Nevada, United States, 89014
Status
Study Complete
Location
GSK Investigational Site
Hialeah, Florida, United States, 33016
Status
Study Complete
Location
GSK Investigational Site
Hlucin, Czech Republic, 748 01
Status
Study Complete
Location
GSK Investigational Site
Hoechstadt, Bayern, Germany, 91315
Status
Study Complete
Location
GSK Investigational Site
Holland, Pennsylvania, United States, 18966
Status
Study Complete
Location
GSK Investigational Site
Hollywood, Maryland, United States, 20636
Status
Study Complete
Location
GSK Investigational Site
Houston, Texas, United States, 77034
Status
Study Complete
Location
GSK Investigational Site
Houston, Texas, United States, 77043
Status
Study Complete
Location
GSK Investigational Site
Houston, Texas, United States, 77055
Status
Study Complete
Location
GSK Investigational Site
Houston, Texas, United States, 77077
Status
Study Complete
Location
GSK Investigational Site
Houston, Texas, United States, 77079
Status
Study Complete
Location
GSK Investigational Site
Huntingdon Valley, Pennsylvania, United States, 19006
Status
Study Complete
Location
GSK Investigational Site
Huntington Beach, California, United States, 92647
Status
Study Complete
Location
GSK Investigational Site
Hyannis, Massachusetts, United States, 02601
Status
Study Complete
Location
GSK Investigational Site
Illescas-Toledo, Spain, 45004
Status
Study Complete
Location
GSK Investigational Site
Incheon, South Korea, 402-751
Status
Study Complete
Location
GSK Investigational Site
Indianapolis, Indiana, United States, 46208
Status
Study Complete
Location
GSK Investigational Site
Indianapolis, Indiana, United States, 46256
Status
Study Complete
Location
GSK Investigational Site
Interlochen, Michigan, United States, 49643
Status
Study Complete
Location
GSK Investigational Site
Iowa City, Iowa, United States, 52242
Status
Study Complete
Location
GSK Investigational Site
Ivano-Frankivsk, Ukraine, 76008
Status
Study Complete
Location
GSK Investigational Site
Jacksonville, Florida, United States, 32205
Status
Study Complete
Location
GSK Investigational Site
Jakarta, Indonesia, 10430
Status
Study Complete
Location
GSK Investigational Site
Jakarta, Indonesia, 13230
Status
Study Complete
Location
GSK Investigational Site
Jakarta, Indonesia, 13630
Status
Study Complete
Location
GSK Investigational Site
Jambes, Belgium, 5100
Status
Study Complete
Location
GSK Investigational Site
Jaromer, Czech Republic, 551 01
Status
Study Complete
Location
GSK Investigational Site
Jenkintown, Pennsylvania, United States, 19046
Status
Study Complete
Location
GSK Investigational Site
Johnston, Rhode Island, United States, 02919
Status
Study Complete
Location
GSK Investigational Site
Jupiter, Florida, United States, 33458
Status
Study Complete
Location
GSK Investigational Site
KAOHSIUNG, Taiwan, 824
Status
Study Complete
Location
GSK Investigational Site
Kalamazoo, Michigan, United States, 49009
Status
Study Complete
Location
GSK Investigational Site
Kansas City, Missouri, United States, 64114
Status
Study Complete
Location
GSK Investigational Site
Kansas City, Missouri, United States, 64138
Status
Study Complete
Location
GSK Investigational Site
Kaohsiung, Taiwan, 833
Status
Study Complete
Location
GSK Investigational Site
Kaposvár, Hungary, 7400
Status
Study Complete
Location
GSK Investigational Site
Katy, Texas, United States, 77450
Status
Study Complete
Location
GSK Investigational Site
Kaunas, Lithuania, LT-49456
Status
Study Complete
Location
GSK Investigational Site
Kaunas, Lithuania, LT-50009
Status
Study Complete
Location
GSK Investigational Site
Kaunas, Lithuania, LT-50128
Status
Study Complete
Location
GSK Investigational Site
Keelung, Taiwan, 20401
Status
Study Complete
Location
GSK Investigational Site
Kemerovo, Russia, 650000
Status
Study Complete
Location
GSK Investigational Site
Kemerovo, Russia, 650002
Status
Study Complete
Location
GSK Investigational Site
Kent, United Kingdom, CT5 3QU
Status
Study Complete
Location
GSK Investigational Site
Kerrville, Texas, United States, 78028
Status
Study Complete
Location
GSK Investigational Site
Kharkiv, Ukraine, 61002
Status
Study Complete
Location
GSK Investigational Site
Kiev, Ukraine, 03680
Status
Study Complete
Location
GSK Investigational Site
Killeen, Texas, United States, 76542
Status
Study Complete
Location
GSK Investigational Site
Kingston, Ontario, Canada, K7L 2V6
Status
Study Complete
Location
GSK Investigational Site
Kingwood, Texas, United States, 77339
Status
Study Complete
Location
GSK Investigational Site
Kirov, Russia, 610027
Status
Study Complete
Location
GSK Investigational Site
Klaipeda, Lithuania, LT-92288
Status
Study Complete
Location
GSK Investigational Site
Klappholz, Schleswig-Holstein, Germany, 24860
Status
Study Complete
Location
GSK Investigational Site
Kleve-Materborn, Nordrhein-Westfalen, Germany, 47533
Status
Study Complete
Location
GSK Investigational Site
Koblenz, Rheinland-Pfalz, Germany, 56068
Status
Study Complete
Location
GSK Investigational Site
Komló, Hungary, 7300
Status
Study Complete
Location
GSK Investigational Site
Kota Bharu, Malaysia, 15886
Status
Study Complete
Location
GSK Investigational Site
Krakow, Poland, 31-202
Status
Study Complete
Location
GSK Investigational Site
Krasnodar, Russia, 350063
Status
Study Complete
Location
GSK Investigational Site
Krasnoyarsk, Russia, 660022
Status
Study Complete
Location
GSK Investigational Site
Krefeld, Nordrhein-Westfalen, Germany, 47798
Status
Study Complete
Location
GSK Investigational Site
Krugersdorp, Gauteng, South Africa, 1752
Status
Study Complete
Location
GSK Investigational Site
Kryvyi Rih, Ukraine, 50082
Status
Study Complete
Location
GSK Investigational Site
Kuala Pilah, Malaysia, 72000
Status
Study Complete
Location
GSK Investigational Site
Kuldiga, Latvia, LV - 3301
Status
Study Complete
Location
GSK Investigational Site
Kyiv, Ukraine
Status
Study Complete
Location
GSK Investigational Site
La Plata, Argentina, B1902COS
Status
Study Complete
Location
GSK Investigational Site
Lake Oswego, Oregon, United States, 97035
Status
Study Complete
Location
GSK Investigational Site
Landsdale, Pennsylvania, United States, 19446
Status
Study Complete
Location
GSK Investigational Site
Lansdale, Pennsylvania, United States, 19446
Status
Study Complete
Location
GSK Investigational Site
Lanús, Buenos Aires, Argentina, B1824KAJ
Status
Study Complete
Location
GSK Investigational Site
Largo, Maryland, United States, 20774
Status
Study Complete
Location
GSK Investigational Site
Las Pinas, Philippines, 1470
Status
Study Complete
Location
GSK Investigational Site
Las Vegas, Nevada, United States, 89106
Status
Study Complete
Location
GSK Investigational Site
Las Vegas, Nevada, United States, 89107
Status
Study Complete
Location
GSK Investigational Site
Las Vegas, Nevada, United States, 89183
Status
Study Complete
Location
GSK Investigational Site
Latrobe, Pennsylvania, United States, 15650
Status
Study Complete
Location
GSK Investigational Site
Lawrenceville, Georgia, United States, 30045
Status
Study Complete
Location
GSK Investigational Site
Layton, Utah, United States, 84041
Status
Study Complete
Location
GSK Investigational Site
Leicester, United Kingdom, LE2 7LX
Status
Study Complete
Location
GSK Investigational Site
Leipzig, Sachsen, Germany, 04357
Status
Study Complete
Location
GSK Investigational Site
Lewisville, Texas, United States, 75067
Status
Study Complete
Location
GSK Investigational Site
Lexington, Kentucky, United States, 40509
Status
Study Complete
Location
GSK Investigational Site
Lexington, North Carolina, United States, 27295
Status
Study Complete
Location
GSK Investigational Site
Libiaz, Poland, 32-590
Status
Study Complete
Location
GSK Investigational Site
Lilburn, Georgia, United States, 30047
Status
Study Complete
Location
GSK Investigational Site
Lima, Peru, L 33
Status
Study Complete
Location
GSK Investigational Site
Lima, Peru, Lima 18
Status
Study Complete
Location
GSK Investigational Site
Lima, Lima, Peru, Lima 1
Status
Study Complete
Location
GSK Investigational Site
Lincoln, Nebraska, United States, 02865
Status
Study Complete
Location
GSK Investigational Site
Lincoln, Nebraska, United States, 68512
Status
Study Complete
Location
GSK Investigational Site
Liverpool, Merseyside, United Kingdom, L7 8XP
Status
Study Complete
Location
GSK Investigational Site
Lodz, Poland, 90-302
Status
Study Complete
Location
GSK Investigational Site
Lodz, Poland, 90-430
Status
Study Complete
Location
GSK Investigational Site
Lodz, Poland, 91-357
Status
Study Complete
Location
GSK Investigational Site
Lodz, Poland, 93-513
Status
Study Complete
Location
GSK Investigational Site
Lomita, California, United States, 90717
Status
Study Complete
Location
GSK Investigational Site
London, London, United Kingdom, E9 6SR
Status
Study Complete
Location
GSK Investigational Site
Long Beach, California, United States, 90806
Status
Study Complete
Location
GSK Investigational Site
Long Beach, California, United States, 90807
Status
Study Complete
Location
GSK Investigational Site
Long Beach, California, United States, 90813
Status
Study Complete
Location
GSK Investigational Site
Los Angeles, California, United States, 90057
Status
Study Complete
Location
GSK Investigational Site
Los Banos, Philippines, 4030
Status
Study Complete
Location
GSK Investigational Site
Louisville, Kentucky, United States, 40291
Status
Study Complete
Location
GSK Investigational Site
Lubin, Poland, 59-300
Status
Study Complete
Location
GSK Investigational Site
Lublin, Poland, 20-093
Status
Study Complete
Location
GSK Investigational Site
Lufkin, Texas, United States, 75904
Status
Study Complete
Location
GSK Investigational Site
Lumberton, New Jersey, United States, 08048
Status
Study Complete
Location
GSK Investigational Site
Lviv, Ukraine, 79059
Status
Study Complete
Location
GSK Investigational Site
Madison, Wisconsin, United States, 53792-9988
Status
Study Complete
Location
GSK Investigational Site
Malang, Indonesia, 65100
Status
Study Complete
Location
GSK Investigational Site
Manchester, Greater Manchester, United Kingdom, M20 2RN
Status
Study Complete
Location
GSK Investigational Site
Mannheim, Baden-Wuerttemberg, Germany, 68161
Status
Study Complete
Location
GSK Investigational Site
Mannheim, Baden-Wuerttemberg, Germany, 68167
Status
Study Complete
Location
GSK Investigational Site
Marion, Ohio, United States, 43302
Status
Study Complete
Location
GSK Investigational Site
Marlton, New Jersey, United States, 08053
Status
Study Complete
Location
GSK Investigational Site
Mataro, Spain, 08303
Status
Study Complete
Location
GSK Investigational Site
McKinney, Texas, United States, 75071
Status
Study Complete
Location
GSK Investigational Site
Meissen, Sachsen, Germany, 1662
Status
Study Complete
Location
GSK Investigational Site
Melbourne, Florida, United States, 32935
Status
Study Complete
Location
GSK Investigational Site
Mendoza, Argentina, 5500
Status
Study Complete
Location
GSK Investigational Site
Merseyside, United Kingdom, CH41 0DD
Status
Study Complete
Location
GSK Investigational Site
Mesa, Arizona, United States, 85203
Status
Study Complete
Location
GSK Investigational Site
Mesa, Arizona, United States, 85206
Status
Study Complete
Location
GSK Investigational Site
Miami, Florida, United States, 33015
Status
Study Complete
Location
GSK Investigational Site
Miami, Florida, United States, 33125
Status
Study Complete
Location
GSK Investigational Site
Miami, Florida, United States, 33155
Status
Study Complete
Location
GSK Investigational Site
Miami, Florida, United States, 33156
Status
Study Complete
Location
GSK Investigational Site
Miami, Florida, United States, 33165
Status
Study Complete
Location
GSK Investigational Site
Miami, Florida, United States, 33175
Status
Study Complete
Location
GSK Investigational Site
Middelburg, South Africa, 1050
Status
Study Complete
Location
GSK Investigational Site
Middleburg Heights, Ohio, United States, 44130
Status
Study Complete
Location
GSK Investigational Site
Midlothian, Virginia, United States, 23114
Status
Study Complete
Location
GSK Investigational Site
Midvale, Utah, United States, 84047
Status
Study Complete
Location
GSK Investigational Site
Milano, Italy, 20122
Status
Study Complete
Location
GSK Investigational Site
Milano, Italy, 20142
Status
Study Complete
Location
GSK Investigational Site
Milano, Italy, 20157
Status
Study Complete
Location
GSK Investigational Site
Milano, Lombardia, Italy, 20157
Status
Study Complete
Location
GSK Investigational Site
Milano, Lombardia, Italy, 20162
Status
Study Complete
Location
GSK Investigational Site
Milford, Connecticut, United States, 06460
Status
Study Complete
Location
GSK Investigational Site
Minneapolis, Minnesota, United States, 55440
Status
Study Complete
Location
GSK Investigational Site
Mississauga, Ontario, Canada, L4T 4J2
Status
Study Complete
Location
GSK Investigational Site
Mobile, Alabama, United States, 36608
Status
Study Complete
Location
GSK Investigational Site
Monterrey, Mexico, 64710
Status
Study Complete
Location
GSK Investigational Site
Montgomery, Alabama, United States, 36109
Status
Study Complete
Location
GSK Investigational Site
Monza, Italy, 20052
Status
Study Complete
Location
GSK Investigational Site
Morganton, North Carolina, United States, 28655
Status
Study Complete
Location
GSK Investigational Site
Morgantown, West Virginia, United States, 26505
Status
Study Complete
Location
GSK Investigational Site
Moscow, Russia, 110020
Status
Study Complete
Location
GSK Investigational Site
Moscow, Russia, 115432
Status
Study Complete
Location
GSK Investigational Site
Moscow, Russia, 119121
Status
Study Complete
Location
GSK Investigational Site
Moscow, Russia, 123182
Status
Study Complete
Location
GSK Investigational Site
Moscow, Russia, 125167
Status
Study Complete
Location
GSK Investigational Site
Moscow, Russia, 127018
Status
Study Complete
Location
GSK Investigational Site
Muenster, Nordrhein-Westfalen, Germany, 48149
Status
Study Complete
Location
GSK Investigational Site
Muncie, Indiana, United States, 47304-5547
Status
Study Complete
Location
GSK Investigational Site
Murray, Utah, United States, 84107
Status
Study Complete
Location
GSK Investigational Site
Nagykanizsa, Hungary, 08800
Status
Study Complete
Location
GSK Investigational Site
Napa, California, United States, 94558
Status
Study Complete
Location
GSK Investigational Site
Neuoetting, Bayern, Germany, 84524
Status
Study Complete
Location
GSK Investigational Site
Neuss, Nordrhein-Westfalen, Germany, 41469
Status
Study Complete
Location
GSK Investigational Site
New Port Richey, Florida, United States, 34652
Status
Study Complete
Location
GSK Investigational Site
New Windsor, New York, United States, 12553
Status
Study Complete
Location
GSK Investigational Site
New York, New York, United States, 10022 11209
Status
Study Complete
Location
GSK Investigational Site
Newmarket, Ontario, Canada, L3Y 5G8
Status
Study Complete
Location
GSK Investigational Site
Newport Beach, California, United States, 92663
Status
Study Complete
Location
GSK Investigational Site
Niles, Michigan, United States, 49120
Status
Study Complete
Location
GSK Investigational Site
Norfolk, Virginia, United States, 23507
Status
Study Complete
Location
GSK Investigational Site
Normal, Illinois, United States, 61761
Status
Study Complete
Location
GSK Investigational Site
Novi, Michigan, United States, 48375
Status
Study Complete
Location
GSK Investigational Site
Novosibirsk, Russia, 630051
Status
Study Complete
Location
GSK Investigational Site
Novosibirsk, Russia, 630087
Status
Study Complete
Location
GSK Investigational Site
Novosibirsk, Russia, 630089
Status
Study Complete
Location
GSK Investigational Site
Novosibirsk, Russia, 630091
Status
Study Complete
Location
GSK Investigational Site
Novosibirsk, Russia, 630099
Status
Study Complete
Location
GSK Investigational Site
Nueve de Julio, Buenos Aires, Argentina, B6500BWQ
Status
Study Complete
Location
GSK Investigational Site
Oak Lawn, Illinois, United States, 60453
Status
Study Complete
Location
GSK Investigational Site
Ocean, New Jersey, United States, 07712
Status
Study Complete
Location
GSK Investigational Site
Odesa, Ukraine, 65010
Status
Study Complete
Location
GSK Investigational Site
Oklahoma City, Oklahoma, United States, 73103
Status
Study Complete
Location
GSK Investigational Site
Oklahoma City, Oklahoma, United States, 73112
Status
Study Complete
Location
GSK Investigational Site
Oklahoma City, Oklahoma, United States, 73120
Status
Study Complete
Location
GSK Investigational Site
Olsztyn, Poland, 10-357
Status
Study Complete
Location
GSK Investigational Site
Omaha, Nebraska, United States, 68130
Status
Study Complete
Location
GSK Investigational Site
Orenburg, Russia, 460018
Status
Study Complete
Location
GSK Investigational Site
Orlando, Florida, United States, 32806
Status
Study Complete
Location
GSK Investigational Site
Orlando, Florida, United States, 32811
Status
Study Complete
Location
GSK Investigational Site
Orlando, Florida, United States, 32822
Status
Study Complete
Location
GSK Investigational Site
Overland Park, Kansas, United States, 66210
Status
Study Complete
Location
GSK Investigational Site
Oxnard, California, United States, 93030
Status
Study Complete
Location
GSK Investigational Site
Palembang, Indonesia, 30126
Status
Study Complete
Location
GSK Investigational Site
Palermo, Sicilia, Italy, 90146
Status
Study Complete
Location
GSK Investigational Site
Parana, Entre Ríos, Argentina, E3100BHK
Status
Study Complete
Location
GSK Investigational Site
Parkville, Australia, 3052
Status
Study Complete
Location
GSK Investigational Site
Parma, Emilia-Romagna, Italy, 43125
Status
Study Complete
Location
GSK Investigational Site
Pavia, Lombardia, Italy, 27100
Status
Study Complete
Location
GSK Investigational Site
Pazardjik, Bulgaria, 4400
Status
Study Complete
Location
GSK Investigational Site
Pell City, Alabama, United States, 35128
Status
Study Complete
Location
GSK Investigational Site
Pensacola, Florida, United States, 32514
Status
Study Complete
Location
GSK Investigational Site
Penzance, United Kingdom, TK19 7HX
Status
Study Complete
Location
GSK Investigational Site
Peoria, Arizona, United States, 85381
Status
Study Complete
Location
GSK Investigational Site
Philadelphia, Pennsylvania, United States, 19115
Status
Study Complete
Location
GSK Investigational Site
Philadelphia, Pennsylvania, United States, 19152
Status
Study Complete
Location
GSK Investigational Site
Phoenix, Arizona, United States, 85050
Status
Study Complete
Location
GSK Investigational Site
Phoenix, Arizona, United States, 92120-4915
Status
Study Complete
Location
GSK Investigational Site
Pinellas Park, Florida, United States, 33781
Status
Study Complete
Location
GSK Investigational Site
Pittsburgh, Pennsylvania, United States, 15206
Status
Study Complete
Location
GSK Investigational Site
Pittsburgh, Pennsylvania, United States, 15212
Status
Study Complete
Location
GSK Investigational Site
Pittsburgh, Pennsylvania, United States, 15236
Status
Study Complete
Location
GSK Investigational Site
Plano, Texas, United States, 75024
Status
Study Complete
Location
GSK Investigational Site
Plano, Texas, United States, 75075
Status
Study Complete
Location
GSK Investigational Site
Plovdiv, Bulgaria, 4000
Status
Study Complete
Location
GSK Investigational Site
Plzen, Czech Republic, 301 00
Status
Study Complete
Location
GSK Investigational Site
Plzen, Czech Republic, 323 00
Status
Study Complete
Location
GSK Investigational Site
Poltava, Ukraine, 36011
Status
Study Complete
Location
GSK Investigational Site
Pomona, California, United States, 91767
Status
Study Complete
Location
GSK Investigational Site
Port Elizabeth, Eastern Cape, South Africa, 6014
Status
Study Complete
Location
GSK Investigational Site
Port Gibson, Mississippi, United States, 39150
Status
Study Complete
Location
GSK Investigational Site
Port Orchard, Washington, United States, 98366
Status
Study Complete
Location
GSK Investigational Site
Portland, Maine, United States, 4101
Status
Study Complete
Location
GSK Investigational Site
Potsdam, Brandenburg, Germany, 14467
Status
Study Complete
Location
GSK Investigational Site
Poznan, Poland, 60-214
Status
Study Complete
Location
GSK Investigational Site
Pozuelo de Alarcón/Madrid, Spain, 28223
Status
Study Complete
Location
GSK Investigational Site
Praha 1, Czech Republic, 110 00
Status
Study Complete
Location
GSK Investigational Site
Praha 13, Czech Republic, 158 00
Status
Study Complete
Location
GSK Investigational Site
Praha 4, Czech Republic, 140 00
Status
Study Complete
Location
GSK Investigational Site
Praha 6, Czech Republic, 163 00
Status
Study Complete
Location
GSK Investigational Site
Praha 6, Czech Republic, 169 00
Status
Study Complete
Location
GSK Investigational Site
Pretoria, South Africa, 0001
Status
Study Complete
Location
GSK Investigational Site
Pretoria, South Africa, 0002
Status
Study Complete
Location
GSK Investigational Site
Pretoria, Gauteng, South Africa, 0181
Status
Study Complete
Location
GSK Investigational Site
Pulilan, Philippines, 3005
Status
Study Complete
Location
GSK Investigational Site
Puyallup, Washington, United States, 98371
Status
Study Complete
Location
GSK Investigational Site
Pyatigorsk, Russia, 357538
Status
Study Complete
Location
GSK Investigational Site
Quezon City, Philippines, 1100
Status
Study Complete
Location
GSK Investigational Site
Rackeve, Hungary, 2300
Status
Study Complete
Location
GSK Investigational Site
Radomsko, Poland, 97-500
Status
Study Complete
Location
GSK Investigational Site
Randwick, New South Wales, Australia, 2031
Status
Study Complete
Location
GSK Investigational Site
Rapid City, South Dakota, United States, 57702
Status
Study Complete
Location
GSK Investigational Site
Rathenow, Brandenburg, Germany, 14712
Status
Study Complete
Location
GSK Investigational Site
Ratingen, Nordrhein-Westfalen, Germany, 40878
Status
Study Complete
Location
GSK Investigational Site
Raubach, Rheinland-Pfalz, Germany, 56316
Status
Study Complete
Location
GSK Investigational Site
Redcliffe, Queensland, Australia, 4020
Status
Study Complete
Location
GSK Investigational Site
Reinfeld, Schleswig-Holstein, Germany, 23858
Status
Study Complete
Location
GSK Investigational Site
Rhaunen, Rheinland-Pfalz, Germany, 55624
Status
Study Complete
Location
GSK Investigational Site
Richmond, Virginia, United States, 23223
Status
Study Complete
Location
GSK Investigational Site
Richmond, Virginia, United States, 23229
Status
Study Complete
Location
GSK Investigational Site
Richmond, Virginia, United States, 23233
Status
Study Complete
Location
GSK Investigational Site
Richmond, Virginia, United States, 23235
Status
Study Complete
Location
GSK Investigational Site
Ridgewood, New Jersey, United States, 07450
Status
Study Complete
Location
GSK Investigational Site
Riga, Latvia, LV 1003
Status
Study Complete
Location
GSK Investigational Site
Riga, Latvia, LV1038
Status
Study Complete
Location
GSK Investigational Site
Rincon, Georgia, United States, 31326
Status
Study Complete
Location
GSK Investigational Site
Rodgau, Hessen, Germany, 63110
Status
Study Complete
Location
GSK Investigational Site
Rolling Hills Estates, California, United States, 90274
Status
Study Complete
Location
GSK Investigational Site
Roma, Lazio, Italy, 00135
Status
Study Complete
Location
GSK Investigational Site
Roma, Lazio, Italy, 00157
Status
Study Complete
Location
GSK Investigational Site
Roma, Lazio, Italy, 00165
Status
Study Complete
Location
GSK Investigational Site
Rosario, Argentina, S2000BRH
Status
Study Complete
Location
GSK Investigational Site
Rosario, Santa Fe, Argentina, S2000JKR
Status
Study Complete
Location
GSK Investigational Site
Roseville, California, United States, 95678
Status
Study Complete
Location
GSK Investigational Site
Rosklide, Denmark, DK-4000
Status
Study Complete
Location
GSK Investigational Site
Rostov-on-Don, Russia, 344091
Status
Study Complete
Location
GSK Investigational Site
Ruda Slaska, Poland, 41-709
Status
Study Complete
Location
GSK Investigational Site
Rudka, Poland, 05-320
Status
Study Complete
Location
GSK Investigational Site
Ruesselsheim, Hessen, Germany, 65428
Status
Study Complete
Location
GSK Investigational Site
Ryazan, Russia, 390026
Status
Study Complete
Location
GSK Investigational Site
Rzeszow, Poland, 35-241
Status
Study Complete
Location
GSK Investigational Site
Saarbruecken, Saarland, Germany, 66111
Status
Study Complete
Location
GSK Investigational Site
Sabadell (Barcelona), Spain, 08208
Status
Study Complete
Location
GSK Investigational Site
Sacramento, California, United States, 95823
Status
Study Complete
Location
GSK Investigational Site
Sacramento, California, United States, 95841
Status
Study Complete
Location
GSK Investigational Site
Sagunto/Valencia, Spain, 46520
Status
Study Complete
Location
GSK Investigational Site
Saint Petersburg, Russia, 192212
Status
Study Complete
Location
GSK Investigational Site
Saint Petersburg, Russia, 195067
Status
Study Complete
Location
GSK Investigational Site
Saint Petersburg, Russia, 196084
Status
Study Complete
Location
GSK Investigational Site
Saint Petersburg, Russia, 196657
Status
Study Complete
Location
GSK Investigational Site
Saint-Petersburg, Russia, 194354
Status
Study Complete
Location
GSK Investigational Site
Saint-Petersburg, Russia, 195112
Status
Study Complete
Location
GSK Investigational Site
San Antonio, Texas, United States, 78229
Status
Study Complete
Location
GSK Investigational Site
San Antonio, Texas, United States, 78233
Status
Study Complete
Location
GSK Investigational Site
San Antonio, Texas, United States, 78251
Status
Study Complete
Location
GSK Investigational Site
San Antonio, Texas, United States, 78258
Status
Study Complete
Location
GSK Investigational Site
San Borja, Lima, Peru, L36
Status
Study Complete
Location
GSK Investigational Site
San Gabriel, California, United States, 91776
Status
Study Complete
Location
GSK Investigational Site
San Jose, California, United States, 95116
Status
Study Complete
Location
GSK Investigational Site
San Marcos, California, United States, 92078-4081
Status
Study Complete
Location
GSK Investigational Site
San Marino, California, United States, 91108
Status
Study Complete
Location
GSK Investigational Site
San Martin, Buenos Aires, Argentina, 1650
Status
Study Complete
Location
GSK Investigational Site
San Miguel de Tucuman, Tucumán, Argentina, 4000
Status
Study Complete
Location
GSK Investigational Site
San Ramon, California, United States, 94583
Status
Study Complete
Location
GSK Investigational Site
Sant Boi de Llobregat, Spain, 08830
Status
Study Complete
Location
GSK Investigational Site
Santa Monica, California, United States, 90404
Status
Study Complete
Location
GSK Investigational Site
Santiago, Chile, 7560994
Status
Study Complete
Location
GSK Investigational Site
Santiago de Compostela, Spain, 15706
Status
Study Complete
Location
GSK Investigational Site
Saratov, Russia, 410018
Status
Study Complete
Location
GSK Investigational Site
Schwalmstadt, Hessen, Germany, 34613
Status
Study Complete
Location
GSK Investigational Site
Scottsboro, Alabama, United States, 35768
Status
Study Complete
Location
GSK Investigational Site
Selangor, Malaysia, 68100
Status
Study Complete
Location
GSK Investigational Site
Semarang, Indonesia, 50242
Status
Study Complete
Location
GSK Investigational Site
Senj, Croatia, 53270
Status
Study Complete
Location
GSK Investigational Site
Seoul, South Korea, 110-744
Status
Study Complete
Location
GSK Investigational Site
Sesto San Giovanni, Italy, 20099
Status
Study Complete
Location
GSK Investigational Site
Shaker Heights, Ohio, United States, 44120
Status
Study Complete
Location
GSK Investigational Site
Shelby, North Carolina, United States, 28152
Status
Study Complete
Location
GSK Investigational Site
Shelbyville, Tennessee, United States, 37160
Status
Study Complete
Location
GSK Investigational Site
Shiloh, Illinois, United States, 62269
Status
Study Complete
Location
GSK Investigational Site
Shippensburg, Pennsylvania, United States, 17257
Status
Study Complete
Location
GSK Investigational Site
Siauliai, Lithuania, LT-76231
Status
Study Complete
Location
GSK Investigational Site
Sibiu, Romania, 550166
Status
Study Complete
Location
GSK Investigational Site
Sierra Vista, Arizona, United States, 85635
Status
Study Complete
Location
GSK Investigational Site
Silver Spring, Maryland, United States, 20910
Status
Study Complete
Location
GSK Investigational Site
Simferopol, Ukraine, 95006
Status
Study Complete
Location
GSK Investigational Site
Sioux Falls, South Dakota, United States, 57108
Status
Study Complete
Location
GSK Investigational Site
Siófok, Hungary, 8600
Status
Study Complete
Location
GSK Investigational Site
Sliven, Bulgaria, 8800
Status
Study Complete
Location
GSK Investigational Site
Sofia, Bulgaria, 1000
Status
Study Complete
Location
GSK Investigational Site
Sofia, Bulgaria, 1463
Status
Study Complete
Location
GSK Investigational Site
Solingen, Nordrhein-Westfalen, Germany, 42651
Status
Study Complete
Location
GSK Investigational Site
Somerset West, South Africa, 7130
Status
Study Complete
Location
GSK Investigational Site
Sopot, Poland, 81-741
Status
Study Complete
Location
GSK Investigational Site
Soweto, South Africa, 2013
Status
Study Complete
Location
GSK Investigational Site
Spokane, Washington, United States, 99204
Status
Study Complete
Location
GSK Investigational Site
Springfield, Ohio, United States, 45504
Status
Study Complete
Location
GSK Investigational Site
St Petersburg, Florida, United States, 33707
Status
Study Complete
Location
GSK Investigational Site
St. Cloud, Florida, United States, 34769
Status
Study Complete
Location
GSK Investigational Site
St. Petersburg, Russia, 197022
Status
Study Complete
Location
GSK Investigational Site
St. Petersburg, Florida, United States, 33710
Status
Study Complete
Location
GSK Investigational Site
Stevensville, Michigan, United States, 49127
Status
Study Complete
Location
GSK Investigational Site
Stockbridge, Georgia, United States, 30281
Status
Study Complete
Location
GSK Investigational Site
Stoke on Trent, United Kingdom, ST4 6QG
Status
Study Complete
Location
GSK Investigational Site
Suffolk, Virginia, United States, 23435
Status
Study Complete
Location
GSK Investigational Site
Sumy, Ukraine, 40022
Status
Study Complete
Location
GSK Investigational Site
Sungai Buloh, Malaysia, 47000
Status
Study Complete
Location
GSK Investigational Site
Surakarta, Indonesia, 57126
Status
Study Complete
Location
GSK Investigational Site
Surrey, British Columbia, Canada, V35 2N6
Status
Study Complete
Location
GSK Investigational Site
Svitavy, Czech Republic, 568 25
Status
Study Complete
Location
GSK Investigational Site
Szczecin, Poland, 70-111
Status
Study Complete
Location
GSK Investigational Site
Tabor City, North Carolina, United States, 28463
Status
Study Complete
Location
GSK Investigational Site
Taipei, Taiwan
Status
Study Complete
Location
GSK Investigational Site
Tallahassee, Florida, United States, 32308
Status
Study Complete
Location
GSK Investigational Site
Tampa, Florida, United States, 33613
Status
Study Complete
Location
GSK Investigational Site
Tampa, Florida, United States, 33614
Status
Study Complete
Location
GSK Investigational Site
Tampa/Florida, Florida, United States, 33607
Status
Study Complete
Location
GSK Investigational Site
Ternopil, Ukraine, 46000
Status
Study Complete
Location
GSK Investigational Site
Thabazimbi, South Africa
Status
Study Complete
Location
GSK Investigational Site
Thornton, Colorado, United States, 80233
Status
Study Complete
Location
GSK Investigational Site
Toledo, Ohio, United States, 43606
Status
Study Complete
Location
GSK Investigational Site
Toledo, Ohio, United States, 43617
Status
Study Complete
Location
GSK Investigational Site
Tomball, Texas, United States, 77375
Status
Study Complete
Location
GSK Investigational Site
Tomsk, Russia, 634 050
Status
Study Complete
Location
GSK Investigational Site
Tomsk, Russia, 634063
Status
Study Complete
Location
GSK Investigational Site
Toronto, Ontario, Canada, M5T 3A9
Status
Study Complete
Location
GSK Investigational Site
Torrelavega, Spain, 39300
Status
Study Complete
Location
GSK Investigational Site
Towson, Maryland, United States, 21204
Status
Study Complete
Location
GSK Investigational Site
Tremosna, Czech Republic, 330 11
Status
Study Complete
Location
GSK Investigational Site
Trenton, New Jersey, United States, 08611
Status
Study Complete
Location
GSK Investigational Site
Trinity, Florida, United States, 34655
Status
Study Complete
Location
GSK Investigational Site
Trnava, Slovakia, 917 01
Status
Study Complete
Location
GSK Investigational Site
Troyan, Bulgaria, 5600
Status
Study Complete
Location
GSK Investigational Site
Tucker, Georgia, United States, 30084
Status
Study Complete
Location
GSK Investigational Site
Tucscon, Arizona, United States, 85704
Status
Study Complete
Location
GSK Investigational Site
Tukums, Latvia, LV - 3101
Status
Study Complete
Location
GSK Investigational Site
Tuscaloosa, Alabama, United States, 35401
Status
Study Complete
Location
GSK Investigational Site
Tyler, Texas, United States, 75708
Status
Study Complete
Location
GSK Investigational Site
Union, South Carolina, United States, 29379
Status
Study Complete
Location
GSK Investigational Site
Uniontown, Pennsylvania, United States, 15401
Status
Study Complete
Location
GSK Investigational Site
Utena, Lithuania, LT-28151
Status
Study Complete
Location
GSK Investigational Site
Utica, New York, United States, 13502
Status
Study Complete
Location
GSK Investigational Site
Valdivia, Chile, 5090146
Status
Study Complete
Location
GSK Investigational Site
Valencia, Spain, 46026
Status
Study Complete
Location
GSK Investigational Site
Valladolid, Spain, 47012
Status
Study Complete
Location
GSK Investigational Site
Valparaiso, Valparaíso, Chile, 2341131
Status
Study Complete
Location
GSK Investigational Site
Varna, Bulgaria, 9000
Status
Study Complete
Location
GSK Investigational Site
Veliko Tarnovo, Bulgaria, 5000
Status
Study Complete
Location
GSK Investigational Site
Ventura, California, United States, 93003
Status
Study Complete
Location
GSK Investigational Site
Vero Beach, Florida, United States, 32960
Status
Study Complete
Location
GSK Investigational Site
Vic (Barcelona), Spain, 08500
Status
Study Complete
Location
GSK Investigational Site
Vidin, Bulgaria, 3700
Status
Study Complete
Location
GSK Investigational Site
Vilnius, Lithuania, LT -10207
Status
Study Complete
Location
GSK Investigational Site
Vilnius, Lithuania, LT-01117
Status
Study Complete
Location
GSK Investigational Site
Vilnius, Lithuania, LT-08661
Status
Study Complete
Location
GSK Investigational Site
Vilshofen, Bayern, Germany, 94474
Status
Study Complete
Location
GSK Investigational Site
Vinnytsia, Ukraine, 21018
Status
Study Complete
Location
GSK Investigational Site
Virginia Beach, Virginia, United States, 23454
Status
Study Complete
Location
GSK Investigational Site
Vista, California, United States, 92083
Status
Study Complete
Location
GSK Investigational Site
Viña del Mar, Chile, 2570017
Status
Study Complete
Location
GSK Investigational Site
Voronezh, Russia, 394018
Status
Study Complete
Location
GSK Investigational Site
Waco, Texas, United States, 76710
Status
Study Complete
Location
GSK Investigational Site
Waco, Texas, United States, 76712
Status
Study Complete
Location
GSK Investigational Site
Warszawa, Poland, 01-138
Status
Study Complete
Location
GSK Investigational Site
Warszawa, Poland, 01-157
Status
Study Complete
Location
GSK Investigational Site
Warwick, Rhode Island, United States, 02888-3221
Status
Study Complete
Location
GSK Investigational Site
Waterbury, Connecticut, United States, 06708
Status
Study Complete
Location
GSK Investigational Site
Welkom, South Africa, 9460
Status
Study Complete
Location
GSK Investigational Site
Wellington, Florida, United States, 33414
Status
Study Complete
Location
GSK Investigational Site
Wels, Austria, 4600
Status
Study Complete
Location
GSK Investigational Site
West Covina, California, United States, 91790
Status
Study Complete
Location
GSK Investigational Site
West Des Moines, Iowa, United States, 50265
Status
Study Complete
Location
GSK Investigational Site
West Jordan, Utah, United States, 84088
Status
Study Complete
Location
GSK Investigational Site
West Sacramento, California, United States, 95691
Status
Study Complete
Location
GSK Investigational Site
Westfield, New York, United States, 14787
Status
Study Complete
Location
GSK Investigational Site
Westmead, New South Wales, Australia, 2145
Status
Study Complete
Location
GSK Investigational Site
Wheat Ridge, Colorado, United States, 80033
Status
Study Complete
Location
GSK Investigational Site
Wheaton, Maryland, United States, 20902
Status
Study Complete
Location
GSK Investigational Site
Wheeling, Ohio, United States, 26003
Status
Study Complete
Location
GSK Investigational Site
Wien, Austria, 1230
Status
Study Complete
Location
GSK Investigational Site
Wilmington, North Carolina, United States, 28401
Status
Study Complete
Location
GSK Investigational Site
Windsor, Ontario, Canada, N8X 2G1
Status
Study Complete
Location
GSK Investigational Site
Witten, Nordrhein-Westfalen, Germany, 58452
Status
Study Complete
Location
GSK Investigational Site
Wodzislaw Slaski, Poland, 44-300
Status
Study Complete
Location
GSK Investigational Site
Wolfsburg, Niedersachsen, Germany, 38448
Status
Study Complete
Location
GSK Investigational Site
Woolloongabba, Queensland, Australia, 4102
Status
Study Complete
Location
GSK Investigational Site
Wroclaw, Poland, 53-301
Status
Study Complete
Location
GSK Investigational Site
Wroclaw, Poland, 54-239
Status
Study Complete
Location
GSK Investigational Site
Yaroslavl, Russia, 150003
Status
Study Complete
Location
GSK Investigational Site
Youngstown, Ohio, United States, 44501-1790
Status
Study Complete
Location
GSK Investigational Site
Zabrze, Poland, 41 - 800
Status
Study Complete
Location
GSK Investigational Site
Zadar, Croatia, 23000
Status
Study Complete
Location
GSK Investigational Site
Zagreb, Croatia, 10000
Status
Study Complete
Location
GSK Investigational Site
Zanesville, Ohio, United States, 43701
Status
Study Complete
Location
GSK Investigational Site
Zaporizhzhia, Ukraine, 69600
Status
Study Complete
Location
GSK Investigational Site
Zaporizhzhya, Ukraine, 69001
Status
Study Complete
Location
GSK Investigational Site
Zephyrhills, Florida, United States, 33540
Status
Study Complete
Location
GSK Investigational Site
Zerbst, Sachsen-Anhalt, Germany, 39261
Status
Study Complete
Location
GSK Investigational Site
Zgierz, Poland, 95-100
Status
Study Complete
Location
GSK Investigational Site
Zhytomyr, Ukraine, 10002
Status
Study Complete

Study documents

Protocol
Available language(s): English
Clinical study report
Available language(s): English
Scientific result summary
Available language(s): English

If you wish to request for full study report, please contact - [email protected]

Results overview

Results posted on ClinicalTrials.gov

Recruitment status
Completed
Actual primary completion date
2015-23-06
Actual study completion date
2015-23-06

Plain language summaries

Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.

Additional information about the trial

Participate in clinical trial
Additional information
Researchers can use this site to request access to anonymised patient level data and/or supporting documents from clinical studies to conduct further research.
Click here
Access to clinical trial data by researchers
Visit website